Position in SYK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$54,184,819
+$19,312,669 QoQ
Shares Held
164,901
+66.2% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Common Shares in SYK Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Empower Advisory Group, LLC holds $227,276,602 across 6 Medical Devices names. SYK ranks #3 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
948,125 | $97,343,993 | |
| 2 | EW |
Edwards Lifesciences Corp
|
866,719 | $69,406,857 | |
| 3 | SYK |
Stryker Corp
This page
|
164,901 | $54,184,819 | |
| 4 | BSX |
Boston Scientific Corp
|
55,203 | $3,463,988 | |
| 5 | MASI |
Masimo Corp
|
14,105 | $2,508,856 | |
| 6 | MDT |
Medtronic plc
|
4,248 | $368,089 |
All Filings in SYK
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,184,819 | 164,901 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $34,872,150 | 99,218 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $57,835,610 | 156,452 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,168,597 | 152,083 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $54,443,423 | 146,255 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $716,859 | 1,991 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $472,166 | 1,307 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $419,528 | 1,233 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $478,472 | 1,337 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $359,651 | 1,201 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $432,859 | 1,584 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $484,482 | 1,588 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $467,314 | 1,637 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||